sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Crispr Therapeutics Market Size & Forecast

Historic: 2022-2024 Base Year: 2025 Forecast: 2026–2033
US$ 172.28 Million
Market Size 2025 · Base Year
US$ 4771.17 Million
Projected Market Size by 2033
51.46%
CAGR · 2026–2033
SHARE
BMIPUB00037547 56+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
56+ countries across North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa
12
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2022–2024), Base Year (2025), and 8-Year Forecast (2026–2033)
10 +
Major Players
Major companies profiled including CRISPR Therapeutics AG, Prime Medicine, Inc., Caribou Biosciences, Inc., Regeneron Pharmaceuticals, Inc., Sangamo Therapeutics, Inc.
350
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • Population growth patterns drive increased consumption of crispr merchandise

  • Retail industry expansion drives demand for innovative crispr merchandise

  • Industrialization in developing regions accelerates crispr demand patterns

Where Growth Opportunities Exist

Key Opportunities

  • Technology licensing enables rapid global market expansion within crispr

  • Emerging economies present significant untapped growth potential for crispr

  • Export market growth presents lucrative international prospects for crispr

What Could Slow It Down

Market Restraints

  • Market fragmentation complicates distribution strategies within crispr

  • Supply chain vulnerabilities affect production stability across crispr

  • Currency fluctuations impact international trade margins within crispr

Market Segmentation

Coverage by Segment

Product

CASGEVY
Others

Indication

Sickle Cell Disease
Transfusion-Dependent Beta Thalassemia
Others

Age Group

Pediatric
Adult

End User

Hospitals
Specialty Treatment Centers
Others
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

CRISPR Therapeutics AG
Prime Medicine, Inc.
Caribou Biosciences, Inc.
Regeneron Pharmaceuticals, Inc.
Sangamo Therapeutics, Inc.
Metagenomi, Inc.
Graphite Bio, Inc.
Scribe Therapeutics
Novartis AG
Precision BioSciences, Inc.
What's Inside

Report Scope & Deliverables

Market Size 2025 US$ 172.28 Million
Market Size 2033 US$ 4771.17 Million
CAGR 2026–2033 51.46%
Segments By Product (CASGEVY, Others)  |  By Indication (Sickle Cell Disease, Transfusion-Dependent Beta Thalassemia, Others)  |  By Age Group (Pediatric, Adult)
Geographies North America (US, Canada, Mexico)  ·  Europe (Germany, Italy, France, U.K., Spain, Belgium, Netherlands, Luxembourg, Norway, Finland, Denmark, Sweden, Switzerland, Austria, Greece, Portugal, Russia, Poland, Romania, Czech Republic, Ukraine, Slovakia, Bulgaria)  ·  Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Taiwan, Bangladesh)  ·  South and Central America (Brazil, Argentina, Chile, Colombia, Peru)  ·  Middle East and Africa (Saudi Arabia, United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIPUB00037547
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 350 pages of in-depth Crispr Therapeutics Market, including historical trends, 8-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.